Protein kinase C activation of intestinal glutamine transport is mediated by mitogen-activated protein kinases.
BACKGROUND
Glutamine is essential for the preservation of intestinal structure and function and its uptake by the bowel is augmented during catabolic states. However, the signal transduction pathways implicated in brush border glutamine transport have not been examined. The aim of this study was to investigate the intracellular signaling pathways involved in the regulation of accelerated intestinal glutamine transport. Our hypothesis was that the activation of intestinal glutamine transport involves protein kinase C (PKC) and is mediated by mitogen-activated protein kinases (MAPKs).


METHODS
[3H]L-Glutamine (50 microM) transport activity and mRNA levels for the intestinal glutamine transporter ATB(0) were measured in intestinal epithelial Caco-2 cells. Confluent cells were treated with phorbol ester (PMA, 0-10 microM), the MAPK MEK inhibitor PD 98059 (0-100 microM), actinomycin (0-0.1 microM), MAPK p38 inhibitor SB 203580 (0-10 microM), protein kinase C inhibitor chelerythrine chloride (0-6.6 microM), or cycloheximide (0-10 microM) for 24 h. Data were analyzed by ANOVA with significance set at P < 0.05.


RESULTS
Phorbol ester treatment increased intestinal System B glutamine transport activity by 75%, an increase that was blocked individually by PD 98059, chelerythrine chloride, actinomycin, and cycloheximide, but not SB 203580, an effect first noted at 6 h. The resulting activity increase was consistent with de novo synthesis of transporter units and enhanced expression of transporter gene ATB(0) as indicated by a threefold increase of ATB(0) mRNA levels in PMA-treated cells.


CONCLUSIONS
Activation of glutamine transport in Caco-2 cells by phorbol ester occurs via signaling pathways that lead to transcription of the glutamine transporter gene. PKC and mitogen-activate protein kinase MEK are key intracellular mediators involved in this signal transduction cascade.
Pan
Ming
M
Department of Surgery, Penn State College of Medicine, Hershey, PA 17033, USA.
Wolfgang
Christopher A
CA
Karinch
Anne M
AM
Lin
ChengMao
C
Meng
QingHe
Q
Vary
Thomas C
TC
Souba
Wiley W
WW
D026962:Amino Acid Transport System ASC / Q000235:genetics / Q000378:metabolism; D018938:Caco-2 Cells; D002273:Carcinogens / Q000494:pharmacology; D015870:Gene Expression / Q000502:physiology; D005973:Glutamine / Q000493:pharmacokinetics*; D006801:Humans; D007422:Intestines / Q000201:enzymology*; D020935:MAP Kinase Signaling System / Q000187:drug effects / Q000502:physiology*; D015778:Minor Histocompatibility Antigens; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism*; D010703:Phorbol Esters / Q000494:pharmacology; D014176:Protein Biosynthesis / Q000502:physiology; D011493:Protein Kinase C / Q000378:metabolism*; D012333:RNA, Messenger / Q000032:analysis; D014158:Transcription, Genetic / Q000502:physiology
D026962:Amino Acid Transport System ASC; D002273:Carcinogens; D015778:Minor Histocompatibility Antigens; D010703:Phorbol Esters; D012333:RNA, Messenger; C420506:SLC1A5 protein, human; D005973:Glutamine; D011493:Protein Kinase C; D020928:Mitogen-Activated Protein Kinases